Devices that interface with the nervous system to read and/or modify its electrical signaling represent the next leap in neuroscience and have great promise for those suffering from debilitating neurological disorders, like epilepsy, psychiatric illnesses, and neurodegenerative diseases.
This intellectual property portfolio from Stanford scientists presents technological solutions to help overcome these challenges and more, enabling the next generation of advanced neurological treatment devices.